Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2022 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The question asks: does management convey that the deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago, so that each new instance of essentially the same business is worth more to the company than the last? We need to look for management's own words about escalation of unit size. The transcript is about Veris Residential, a real estate company transitioning to pure-play multi-family. They talk about selling non-strategic assets, acquiring properties, developing Haus25, etc. But the question is about "successive engagements of the same kind" - meaning the company's own repeatable business. For a REIT, that could be acquisitions, developments, or perhaps leasing? But the question specifically asks about deals, orders, contracts, projects, customers, sites, or programs. In this context, maybe they talk about acquisitions? Or development projects? Or perhaps the size of their property portfolio? But the key is that each new instance is bigger than the last. Looking through the transcript: They mention completing $1.4 billion of non-strategic asset sales, $925 million closed since beginning of 2022. They completed and stabilized Haus25, and acquired The James, adding almost 1,000 units. They increased multi-family NOI share from 56% to 98%. They talk about reducing debt, etc. But is there any statement about the size of deals increasing? They mention selling assets, but that's divestitures. They mention acquisitions: "completed the acquisition of The James" - but no comparison to previous acquisitions. They mention development: Haus25 is a 750-unit tower. But is there any statement that new developments are larger than previous ones? Not really. The question is about "successive engagements of the same kind" - meaning the company's own repeatable business. For a REIT, that could be property acquisitions, or development projects, or perhaps leasing deals? But the transcript focuses on the transformation, not on a pattern of increasing deal size. Look for phrases like "larger", "bigger", "more extensive", "increasing size", etc. I don't see any.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.